ASSET | DATE | % RETURN |
---|---|---|
Applied Opt (AAOI) | 6/1/2023 - 8/30/2023 | 594.98% |
Taysha Gene Therapies (TSHA) | 6/1/2023 - 8/30/2023 | 355.56% |
Spyre Therapeutics (SYRE) | 6/1/2023 - 8/30/2023 | 336.92% |
ASP Isotopes Inc Common Stock (ASPI) | 6/1/2023 - 8/30/2023 | 311.39% |
Innoviz Technologies (INVZW) | 6/1/2023 - 8/30/2023 | 237.08% |
Akso Health Group ADR (AHG) | 6/1/2023 - 8/30/2023 | 174.63% |
Telesat (TSAT) | 6/1/2023 - 8/30/2023 | 150.21% |
Tango Therapeutics (TNGX) | 6/1/2023 - 8/30/2023 | 148.13% |
Root (ROOT) | 6/1/2023 - 8/30/2023 | 146.2% |
Oncology Institute (TOI) | 6/1/2023 - 8/30/2023 | 134.88% |
Gyre Therapeutics (GYRE) | 6/1/2023 - 8/30/2023 | 133.42% |
Vera Therapeutics (VERA) | 6/1/2023 - 8/30/2023 | 124.67% |
Pharvaris (PHVS) | 6/1/2023 - 8/30/2023 | 120% |
Groupon (GRPN) | 6/1/2023 - 8/30/2023 | 116.91% |
Tetra Technologies (TTI) | 6/1/2023 - 8/30/2023 | 114.29% |
Fulcrum Therapeutics (FULC) | 6/1/2023 - 8/30/2023 | 106.2% |
SurModics (SRDX) | 6/1/2023 - 8/30/2023 | 105.87% |
TheRealReal (REAL) | 6/1/2023 - 8/30/2023 | 102.36% |
First Foundation (FFWM) | 6/1/2023 - 8/30/2023 | 101.58% |
Neuropace (NPCE) | 6/1/2023 - 8/30/2023 | 95.68% |
Holley (HLLY) | 6/1/2023 - 8/30/2023 | 93.94% |
Ranpak (PACK) | 6/1/2023 - 8/30/2023 | 90.65% |
ThredUp (TDUP) | 6/1/2023 - 8/30/2023 | 90.34% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 6/1/2023 - 8/30/2023 | 90.09% |
Ehang (EH) | 6/1/2023 - 8/30/2023 | 84.24% |